Analysis of the neutralising and protective activity of polyclonal serum and monoclonal antibodies against viruses
Cell Culture Service
Cytrometry Service of the Central Unit for Research in Medicine (UCIM) of the Universitat de València.
Characterisation of the distribution of mutational effects on the biological efficacy of RNA viruses
Characterisation of viral antigenic epitopes
Cytometry Service
Cytrometry Service of the Central Unit for Research in Medicine (UCIM) of the Universitat de València.
Determination of SARS-CoV-2 in environmental samples
Development and assessment of rapid diagnostic methods for gastrointestinal bacterial and viral infections
Development of Rare Respiratoy Diseases cellular models
Development of probiotic microorganisms with protective capacity against viral infections
Development of viral vaccines
Estimation of the mutation rate of animal, plant and bacteriophage viruses (both RNA and DNA)
Evaluation of antiviral compounds on SARS-CoV-2 in the BSL3 (Biosafety level 3 Laboratory)
Evaluation of diagnostic methods
Evaluation of infection rates at the population level through rapid serological tests
High performance trials studying the metabolic pathways involved in the development of Rare Respiratory Diseases
Identification of molecular determinants that condition susceptibility to gastrointestinal viral diseases
Identification of transmission routes, gene introduction and spread, and drug resistance variants in viruses and bacteria
In-vitro and in-vitro estimation of mutation rates of different human viruses of high biomedical relevance, such as HIV-1 or Hepatitis C
Molecular epidemiology studies of viral infections: detection of new genotypes and variants
Pharmacogenetic testing of patients as support for personalised drug prescription
Prediction of physical, chemical and biological properties of compounds
Prediction of physical, chemical and biological properties of compounds through the application of Molecular Topology.
Quantitative estimation of RNA virus mutation rates
Screening for antivirals and antibodies to SARS-CoV-2
Seroepidemiology studies of viral infections
Studies on the experimental evolution of oncolytic viruses for the development of therapeutic applications
Study of evolutionary processes using viruses as model organisms
Study of the evolution of complete genomes and genes in bacteria and viruses
Study of the interactions between enteric virus-host, enteric virus-intestinal microbiota and intestinal microbiota-host
Study of the pathogenic mechanisms and the immune response to infections by the two main enteric viruses (rotavirus and norovirus)
Study of the spread of pathogenic microorganisms (bacteria and viruses) in human populations and natural reservoirs through genetic and genomic analysis for the purposes of epidemiological care and control
